Vifor Pharma AG
Vifor Pharma AG VIFN.SW Peers
See (VIFN.SW) competitors and their performances in Stock Market.
Stock Comparison
VIFN.SW vs SDZ.SW Comparison
VIFN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIFN.SW stands at N/A. In comparison, SDZ.SW has a market cap of 16.38B. Regarding current trading prices, VIFN.SW is priced at $166.15, while SDZ.SW trades at $38.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIFN.SW currently has a P/E ratio of N/A, whereas SDZ.SW's P/E ratio is -1901.50. In terms of profitability, VIFN.SW's ROE is +0.08%, compared to SDZ.SW's ROE of +0.01%. Regarding short-term risk, VIFN.SW is less volatile compared to SDZ.SW. This indicates potentially lower risk in terms of short-term price fluctuations for VIFN.SW.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.